IDEAYA Biosciences, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $288.7M | $55.3M |
| Jun 2022 | — | $269.3M | $49.1M |
| Sep 2022 | — | $368.8M | $102.0M |
| Dec 2022 | — | $349.5M | $68.6M |
| Mar 2023 | — | $333.8M | $67.2M |
| Jun 2023 | — | $501.6M | $102.8M |
| Sep 2023 | — | $508.0M | $151.9M |
| Dec 2023 | — | $621.1M | $157.0M |
| Mar 2024 | — | $935.3M | $108.3M |
| Jun 2024 | — | $931.7M | $183.0M |
| Sep 2024 | — | $1.18B | $400.3M |
| Dec 2024 | — | $1.06B | $84.4M |
| Mar 2025 | — | $1.02B | $130.0M |
| Jun 2025 | — | $959.7M | $114.6M |
| Sep 2025 | — | $1.09B | $298.9M |
| Dec 2025 | — | $1.02B | $112.8M |
| Mar 2026 | — | $937.3M | $157.5M |
| Jun 2026 | — | $1.20B | $272.6M |